Please provide your email address to receive an email when new articles are posted on . The risk for anaphylaxis from IV iron formulations appeared low, although it varied depending on the type of ...

AMSTERDAM, the Netherlands—Disappointing many who hoped this large, randomized, double-blind trial would show a clear win, HEART-FID is the latest trial of iron supplementation in heart failure to ...

First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...

Please provide your email address to receive an email when new articles are posted on . Anemia is a hallmark complication of advanced chronic kidney disease and of multifactorial origin, including ...

Intravenous iron associated with significant reduction in 30-day postoperative mortality and morbidity compared with RBC transfusion. HealthDay News — For patients with preoperative iron deficiency ...

While the risk of anaphylaxis after administration of IV iron product was low among older adults, it was more common after certain iron products, researchers found. The highest adjusted incidence ...

None of the IV iron products were found to be associated with an increased risk of adverse or serious adverse events compared with oral iron The safety profiles of various intravenous (IV) iron ...

Recent review says findings from the PIVOTAL trial should allay concerns about the use of intravenous iron therapy in patients with end-stage renal disease suffering from anemia. Clinicians ...

PRINCETON, N.J., July 16, 2021 /PRNewswire/ — Sandoz, a global leader in generic and biosimilar medicines, today announced the immediate US availability of generic Ferumoxytol, an intravenous medicine ...